Navigation Links
K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Date:7/15/2010

ST. LOUIS, July 15 /PRNewswire-FirstCall/ -- K-V Pharmaceutical Company (NYSE:  KVa/KVb) announced today that Thomas S. McHugh has been appointed Chief Financial Officer, effective immediately.

Mr. McHugh joined K-V in January 2009 as Vice President of Finance and Corporate Controller.  He served as the company's Interim Chief Financial Officer from September 2009 until April 2010 and as the Chief Accounting Officer since February 2010.  He possesses over 20 years of financial management expertise in the areas of regulatory and government compliance, internal and external financial reporting, investor relations, mergers and acquisitions and global finance.  

Greg Divis, Interim Chief Executive Officer of K-V, stated, "Tom has played a key leadership role on our finance team at a time when sound management of our financial resources and return to compliance has never been more vital.  His assumption of the role of CFO will further strengthen our financial management and help K-V as we continue to prepare for the resumption of normal business operations. We believe that Tom will continue to make a positive impact going forward and look forward to his contributions."

Prior to joining K-V, Mr. McHugh was the Managing Director – Global and Corporate Controller with Bearing Point, Inc. from 2005 to 2008; Vice President of Finance, Chief Financial Officer, Treasurer and Chief Accounting Officer with Huttig Building Products, Inc. from 2000 to 2005; and Corporate Controller and Chief Accounting Officer with XTRA Corporation from 1993 to 2000.  Mr. McHugh began his professional career
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 17, 2015 Research and ... of the "G-Protein Coupled Receptors Market: Global ... 2014 - 2022" report to their offering. ... been segmented based on of assay type, therapeutic ... GPCRs market has been categorized into six major ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v4wlnk/key_pharma_news ) ... Pharma News Issue" newsletter to their offering. ... burgeoning oncology pipeline and serves as a statement ... in 2015, with a large-scale potentially transformative acquisition ... Key Pharma News covers all major developments in ...
(Date:7/27/2015)... , July 27, 2015 Research and Markets ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative ... Asia-Pacific, ROW) - Global Forecast to 2019" report ... expected to reach a value of $2.1 Billion by ... of 3.5% during the forecast period. ...
Breaking Medicine Technology:G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
(Date:7/27/2015)... ... ... With a new charity program in the Chico, CA area, Gary Short ... number of deaths and injuries occurring from police pursuits, and announced that they will ... the police to find better and safer ways to conduct pursuits. To support this ...
(Date:7/27/2015)... , ... July 27, 2015 , ... Throughout its 20 ... premier doctors and medical providers working on a lien basis. As the personal ... wide range of providers from chiropractors, to orthopedists, to pain management physicians, to psychologists ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know that tooth ... can incur a lot of stress, pain, discomfort and embarrassment, which is why they ... treatment reaps the benefits of implants with the cost savings of dentures for anyone ...
(Date:7/27/2015)... ... July 27, 2015 , ... Recently, 10 Best ... other respected water brands also made the organization’s list. As its name clearly indicates, ... options available. Here is a description of the top three brands, along with a ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... In a ... treatment programs help restore a healthy lifestyle, The Ranch at Dove Tree in Lubbock ... text guide readers easily through the steps of recovery. Both the nationally recognized collegiate ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Best Water Brand Awards Presented by 10 Best Water 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3
... some NSAIDS, it could prevent buildup of plaque in ... News) -- A class of drugs called gamma-secretase modulators ... suggests. , A hallmark of Alzheimer,s is so-called amyloid ... modulators reduce the production of long pieces of amyloid ...
... June 11th 2008: At least 50% of recent onset ... signs and symptoms) within 36 weeks when following a ... tight control, according to results of a study presented ... European League Against Rheumatism in Paris, France. Results of ...
... June 11, 2008 Understanding the way bacterial cells ... methods for fighting the often persistent and serious infections ... A&M University professor of chemical engineering who not only ... quell their conversation. , Examining Escherichia coli bacteria ...
... Addicted, cells provide early diagnosis; diet could affect changes, ... changes in the DNA,s chemical coding may make the bowel ... turning the switch on in abnormal genes, a new study ... published their findings in the current issue of the ...
... British parents are to be quizzed about their children,s sex ... way the subject is taught to deaf pupils. , The ... of both deaf and hearing primary school children for its ... researchers hope their findings will make SRE more accessible for ...
... Potential Salmonella Risk, APTOS, Calif., June 11 ... raw tomatoes due to possible,contamination with salmonella, the ... tomato products,-- such as sauces, soups, paste, ketchup ... to continue enjoy. In processing tomato products, heat,reaches ...
Cached Medicine News:Health News:New Class of Drugs May Fight Alzheimer's 2Health News:New Class of Drugs May Fight Alzheimer's 3Health News:50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks 2Health News:Chemical engineering researchers identify biofilms that cause infections 2Health News:Chemical engineering researchers identify biofilms that cause infections 3Health News:Chemical engineering researchers identify biofilms that cause infections 4Health News:DNA Coding May Make Bowel Prone to Cancer 2Health News:Study aims to improve sex education for deaf pupils 2Health News:Study aims to improve sex education for deaf pupils 3Health News:Clarity Needed Amidst Tomato Contamination Confusion 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: